{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:06:54Z","timestamp":1789679214756,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100020483","name":"Insmed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12325-024-03064-9","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T08:08:59Z","timestamp":1734336539000},"page":"935-976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Content Validation of the QOL-B-RD and PROMIS-F SF-7a to Measure Respiratory and Fatigue Symptoms of MAC Lung Disease"],"prefix":"10.1007","volume":"42","author":[{"given":"Kelly P.","family":"McCarrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayton W.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Hua","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Touba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Mange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"issue":"1","key":"3064_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1055\/s-0033-1333567","volume":"34","author":"BA Kendall","year":"2013","unstructured":"Kendall BA, Winthrop KL. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013;34(1):87\u201394. https:\/\/doi.org\/10.1055\/s-0033-1333567.","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"3064_CR2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1378\/chest.126.2.566","volume":"126","author":"SK Field","year":"2004","unstructured":"Field SK, Fisher D, Cowie RL. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest. 2004;126(2):566\u201381. https:\/\/doi.org\/10.1378\/chest.126.2.566.","journal-title":"Chest"},{"key":"3064_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/919474","volume":"2014","author":"M Mirsaeidi","year":"2014","unstructured":"Mirsaeidi M, Farshidpour M, Allen MB, Ebrahimi G, Falkinham JO. Highlight on advances in nontuberculous mycobacterial disease in North America. Biomed Res Int. 2014;2014:919474. https:\/\/doi.org\/10.1155\/2014\/919474.","journal-title":"Biomed Res Int"},{"issue":"4","key":"3064_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","volume":"71","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Clin Infect Dis. 2020;71(4):e1\u201336. https:\/\/doi.org\/10.1093\/cid\/ciaa241.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3064_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367\u2013416. https:\/\/doi.org\/10.1164\/rccm.200604-571ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"3064_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","volume":"185","author":"J Adjemian","year":"2012","unstructured":"Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012;185(8):881\u20136. https:\/\/doi.org\/10.1164\/rccm.201111-2016OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3064_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3978\/j.issn.2072-1439.2013.12.24","volume":"6","author":"MM Johnson","year":"2014","unstructured":"Johnson MM, Odell JA. Nontuberculous mycobacterial pulmonary infections. J Thorac Dis. 2014;6(3):210\u201320. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2013.12.24","journal-title":"J Thorac Dis"},{"issue":"11","key":"3064_CR8","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1080\/17476348.2021.1987891","volume":"15","author":"J van Ingen","year":"2021","unstructured":"van Ingen J, Obradovic M, Hassan M, et al. Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex\u2014disease burden, unmet needs, and advances in treatment developments. Expert Rev Respir Med. 2021;15(11):1387\u2013401. https:\/\/doi.org\/10.1080\/17476348.2021.1987891.","journal-title":"Expert Rev Respir Med"},{"issue":"6","key":"3064_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.5588\/ijtld.15.0460","volume":"20","author":"M Hama","year":"2016","unstructured":"Hama M, Ushiki A, Kosaka M, et al. Health-related quality of life in patients with pulmonary non-tuberculous mycobacteria infection. Int J Tuberc Lung Dis. 2016;20(6):747\u201352. https:\/\/doi.org\/10.5588\/ijtld.15.0460.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"3064_CR10","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.rmed.2011.08.004","volume":"105","author":"M Mehta","year":"2011","unstructured":"Mehta M, Marras TK. Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respir Med. 2011;105(11):1718\u201325. https:\/\/doi.org\/10.1016\/j.rmed.2011.08.004.","journal-title":"Respir Med"},{"key":"3064_CR11","unstructured":"US Food and Drug Administration. Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments. Guidance for industry, Food and Drug Administration staff, and other stakeholders. Center for Drug Evaluation and Research, US Food and Drug Administration, Rockville, MD. 2022. https:\/\/www.fda.gov\/media\/159500\/download. Accessed December 5, 2023."},{"key":"3064_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.chest.2020.08.2055","volume":"159","author":"PA Flume","year":"2021","unstructured":"Flume PA, Griffith DE, Chalmers JD, et al. Development of drugs for nontuberculous mycobacterial disease: clinicians\u2019 interpretation of a US Food and Drug Administration workshop. Chest. 2021;159:537\u201343. https:\/\/doi.org\/10.1016\/j.chest.2020.08.2055.","journal-title":"Chest"},{"issue":"11","key":"3064_CR13","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella D, Riley W, Stone A, et al. The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008. J Clin Epidemiol. 2010;63(11):1179\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.011.","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"3064_CR14","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s11136-008-9402-x","volume":"17","author":"C Christodoulou","year":"2008","unstructured":"Christodoulou C, Junghaenel DU, DeWalt DA, Rothrock N, Stone AA. Cognitive interviewing in the evaluation of fatigue items: results from the patient-reported outcomes measurement information system (PROMIS). Qual Life Res. 2008;17(10):1239\u201346. https:\/\/doi.org\/10.1007\/s11136-008-9402-x.","journal-title":"Qual Life Res"},{"key":"3064_CR15","unstructured":"HealthMeasures. Intro to PROMIS. https:\/\/www.healthmeasures.net\/explore-measurement-systems\/promis\/intro-to-promis. Accessed May 17, 2024."},{"issue":"10 Suppl","key":"3064_CR16","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.apmr.2010.08.033","volume":"92","author":"JS Lai","year":"2011","unstructured":"Lai JS, Cella D, Choi S, et al. How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil. 2011;92(10 Suppl):S20\u20137. https:\/\/doi.org\/10.1016\/j.apmr.2010.08.033.","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"3064_CR17","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/01.mlr.0000250483.85507.04","volume":"45","author":"BB Reeve","year":"2007","unstructured":"Reeve BB, Hays RD, Bjorner JB, et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the patient-reported outcomes measurement information system (PROMIS). Med Care. 2007;45(5):S22\u201331. https:\/\/doi.org\/10.1097\/01.mlr.0000250483.85507.04.","journal-title":"Med Care"},{"issue":"2","key":"3064_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1378\/chest.13-1891","volume":"146","author":"AL Quittner","year":"2014","unstructured":"Quittner AL, Marciel KK, Salathe MA, et al. A preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasis. Chest. 2014;146(2):437\u201348. https:\/\/doi.org\/10.1378\/chest.13-1891.","journal-title":"Chest"},{"issue":"1","key":"3064_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/thoraxjnl-2014-205918","volume":"70","author":"AL Quittner","year":"2015","unstructured":"Quittner AL, O\u2019Donnell AE, Salathe MA, et al. Quality of life questionnaire-bronchiectasis: final psychometric analyses and determination of minimal important difference scores. Thorax. 2015;70(1):12\u201320. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-205918.","journal-title":"Thorax"},{"key":"3064_CR20","unstructured":"HealthMeasures. User manual and scoring instructions: PROMIS Fatigue. 2024. https:\/\/www.healthmeasures.net\/administrator\/components\/com_instruments\/uploads\/PROMIS%20Fatigue%20User%20Manual%20and%20Scoring%20Instructions_29May2024.pdf. Accessed 4 June 2024."},{"issue":"4","key":"3064_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/nnr.0000000000000162","volume":"65","author":"S Ameringer","year":"2016","unstructured":"Ameringer S, Elswick RKJ, Menzies V, et al. Psychometric evaluation of the patient-reported outcomes measurement information system fatigue-short form across diverse populations. Nurs Res. 2016;65(4):279\u201389. https:\/\/doi.org\/10.1097\/nnr.0000000000000162.","journal-title":"Nurs Res"},{"key":"3064_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jclinepi.2015.08.037","volume":"73","author":"D Cella","year":"2016","unstructured":"Cella D, Lai J-S, Jensen SE, et al. PROMIS Fatigue item bank had clinical validity across diverse chronic conditions. J Clin Epidemiol. 2016;73:128\u201334. https:\/\/doi.org\/10.1016\/j.jclinepi.2015.08.037.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"3064_CR23","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s11136-011-0011-8","volume":"21","author":"KF Cook","year":"2012","unstructured":"Cook KF, Bamer AM, Roddey TS, et al. A PROMIS fatigue short form for use by individuals who have multiple sclerosis. Qual Life Res. 2012;21(6):1021\u201330. https:\/\/doi.org\/10.1007\/s11136-011-0011-8.","journal-title":"Qual Life Res"},{"issue":"1","key":"3064_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s41687-019-0155-9","volume":"3","author":"SE Yount","year":"2019","unstructured":"Yount SE, Atwood C, Donohue J, et al. Responsiveness of PROMIS\u00ae to change in chronic obstructive pulmonary disease. J Patient Rep Outcomes. 2019;3(1):65. https:\/\/doi.org\/10.1186\/s41687-019-0155-9.","journal-title":"J Patient Rep Outcomes"},{"issue":"8","key":"3064_CR25","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s11136-010-9677-6","volume":"19","author":"KE Lasch","year":"2010","unstructured":"Lasch KE, Marquis P, Vigneux M, et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res. 2010;19(8):1087\u201396. https:\/\/doi.org\/10.1007\/s11136-010-9677-6.","journal-title":"Qual Life Res"},{"key":"3064_CR26","unstructured":"US Food and Drug Administration. Patient-focused drug development: methods to identify what is important to patients. Guidance for industry, Food and Drug Administration staff, and other stakeholders. Center for Drug Evaluation and Research, US Food and Drug Administration, Rockville, MD. 2022. https:\/\/www.fda.gov\/media\/131230\/download. Accessed 30 Oct 2023."},{"issue":"10","key":"3064_CR27","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1164\/rccm.200805-686OC","volume":"178","author":"RD Kim","year":"2008","unstructured":"Kim RD, Greenberg DE, Ehrmantraut ME, et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med. 2008;178(10):1066\u201374. https:\/\/doi.org\/10.1164\/rccm.200805-686OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"3064_CR28","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s10096-015-2432-8","volume":"34","author":"H Kotilainen","year":"2015","unstructured":"Kotilainen H, Valtonen V, Tukiainen P, et al. Clinical findings in relation to mortality in non-tuberculous mycobacterial infections: patients with Mycobacterium avium complex have better survival than patients with other mycobacteria. Eur J Clin Microbiol Infect Dis. 2015;34(9):1909\u201318. https:\/\/doi.org\/10.1007\/s10096-015-2432-8.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3064_CR29","unstructured":"Leitman A. NTM lung disease: patient experiences & preferences. Presented at FDA public workshop: Development of antibacterial drugs for treatment of nontuberculous mycobacterial disease. Silver Spring, MD. 2019. https:\/\/www.fda.gov\/media\/124058\/download. Accessed February 6, 2024."},{"key":"3064_CR30","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3389\/fphys.2018.01285","volume":"9","author":"M Gruet","year":"2018","unstructured":"Gruet M. Fatigue in chronic respiratory diseases: theoretical framework and implications for real-life performance and rehabilitation. Front Physiol. 2018;9:1285. https:\/\/doi.org\/10.3389\/fphys.2018.01285.","journal-title":"Front Physiol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-03064-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-024-03064-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-03064-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T10:52:09Z","timestamp":1738407129000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-024-03064-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3064"],"URL":"https:\/\/doi.org\/10.1007\/s12325-024-03064-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kelly P. McCarrier, Jui-Hua Tsai, and Nancy Touba are employees of OPEN Health, which received funding from Insmed Incorporated to conduct the research activities. Mariam Hassan, Dayton W. Yuen, and Kevin C. Mange are employees of Insmed Incorporated and report stock ownership in Insmed Incorporated.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Institutional review board (IRB) approval was obtained prior to study initiation from WCG-Clinical IRB and the study was conducted in accordance with the Helsinki Declaration of 1964 and its later amendments All data collected were de-identified and treated as confidential in accordance with local, state, and federal law. Unique participant identification numbers were used to protect participant confidentiality. All participants provided informed consent to study participation and data publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}